Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation pathway proteins, also known as clotting factors, are a group of serine proteases and zymogens essential for blood coagulation. They interact in a cascade to form blood clots at sites of vascular injury, preventing excessive bleeding. Deficiencies or dysfunctions can lead to bleeding disorders or pathological thrombosis. The coagulation cascade is divided into the intrinsic, extrinsic, and common pathways. Regulation involves the protein C system, antithrombin, and tissue factor pathway inhibitor (TFPI).
Inhibition of specific coagulation factors (e.g., Factor Xa, Thrombin)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Pathway Proteins (N/A).